Stocks and Investing
Stocks and Investing
Wed, February 2, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, February 1, 2022
Jeff Jones Initiated (VTYX) at Buy and Held Target at $30 on, Feb 1st, 2022
Jeff Jones of Oppenheimer, Initiated "Ventyx Biosciences, Inc." (VTYX) at Buy and Held Target at $30 on, Feb 1st, 2022.
Jeff has made no other calls on VTYX in the last 4 months.
There are 3 other peers that have a rating on VTYX. Out of the 3 peers that are also analyzing VTYX, 0 agree with Jeff's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Jeff
- Josh Schimmer of "Evercore ISI Group" Initiated at Buy and Held Target at $50 on, Monday, November 15th, 2021
- Michael Yee of "Jefferies" Initiated at Strong Buy and Held Target at $30 on, Monday, November 15th, 2021
- Yasmeen Rahimi of "Piper Sandler" Initiated at Buy and Held Target at $50 on, Monday, November 15th, 2021
Contributing Sources